Low-Grade Prostate Cancer: Time to Stop Calling It Cancer

J Clin Oncol. 2022 Sep 20;40(27):3110-3114. doi: 10.1200/JCO.22.00123. Epub 2022 Apr 18.

Authors

Scott E Eggener¹, Alejandro Berlin², Andrew J Vickers³, Gladell P Paner⁴, Howard Wolinsky⁵, Matthew R Cooperberg⁶

Affiliations

¹ Section of Urology, University of Chicago, Chicago, IL.
² Department of Radiation Oncology, University of Toronto, Toronto, Canada.
³ Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY.
⁴ Department of Pathology, University of Chicago, Chicago, IL.
⁵ Patient-Advocate, Answer Cancer Foundation, Chicago, IL.
⁶ Department of Urology, University of California-San Francisco, San Francisco, CA.

PMID: 35436144
DOI: 10.1200/JCO.22.00123

No abstract available

MeSH terms

Humans
Male
Neoplasm Grading
Prostate*
Prostate-Specific Antigen
Prostatic Neoplasms* / therapy

Substances

Prostate-Specific Antigen